Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

Mitchell, SA; Grove, J; Spurkland, A; Boberg, KM; Fleming, KA; Day, CP; Schrumpf, E; Chapman, RW

Abstract:

BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology. Abnormalities in immune regulation and genetic associations suggest that PSC is an immune mediated disease. Several polymorphisms within the tumour necrosis factor alpha (TNF-alpha) and interleukin 10 (IL-10) promoter genes have been described which influence expression of these cytokines. This study examines the possible association between polymorphisms at the -308 and -62...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Mitchell, S. A., Grove, J., Spurkland, A., Boberg, K. M., Fleming, K. A., Day, C. P., Schrumpf, E., & Chapman, R. W. (2001). Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut, 49(2), 288–294.

MLA Style

Mitchell, S. A., et al. “Association of the Tumour Necrosis Factor Alpha -308 but Not the Interleukin 10 -627 Promoter Polymorphism with Genetic Susceptibility to Primary Sclerosing Cholangitis.” Gut, vol. 49, no. 2, 2001, pp. 288–94.

Chicago Style

Mitchell, SA, J Grove, A Spurkland, KM Boberg, KA Fleming, CP Day, E Schrumpf, and RW Chapman. 2001. “Association of the Tumour Necrosis Factor Alpha -308 but Not the Interleukin 10 -627 Promoter Polymorphism with Genetic Susceptibility to Primary Sclerosing Cholangitis.” Gut 49 (2): 288–94.
Tweet
Print